246 related articles for article (PubMed ID: 9660019)
1. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel.
Lockett MA; Baron PL; O'Brien PH; Elliott BM; Robison JG; Maitre N; Metcalf JS; Cole DJ
J Am Coll Surg; 1998 Jul; 187(1):9-16. PubMed ID: 9660019
[TBL] [Abstract][Full Text] [Related]
2. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.
Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
Am J Pathol; 1996 Feb; 148(2):649-56. PubMed ID: 8579127
[TBL] [Abstract][Full Text] [Related]
3. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.
Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients.
Lockett MA; Metcalf JS; Baron PL; O'Brien PH; Elliott BM; Robison JG; Cole DJ
Am Surg; 1998 Jun; 64(6):539-43; discussion 543-4. PubMed ID: 9619175
[TBL] [Abstract][Full Text] [Related]
5. [Detection of breast cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse-transcriptase polymerase chain reaction].
Noguchi S; Aihara T; Motomura K; Inaji H; Koyama H
Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():50-5. PubMed ID: 8702311
[TBL] [Abstract][Full Text] [Related]
6. [The detection of breast carcinoma micrometastases in axillary lymph nodes by reverse transcriptase-polymerase chain reaction].
Zhang Q; Zhang Y; Gu X; Zhang M; Lin H; Qian H
Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):430-2. PubMed ID: 11825433
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer.
Sakaguchi M; Virmani A; Dudak MW; Peters GN; Leitch AM; Saboorian H; Gazdar AF; Euhus DM
Ann Surg Oncol; 2003 Mar; 10(2):117-25. PubMed ID: 12620905
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study.
Gillanders WE; Mikhitarian K; Hebert R; Mauldin PD; Palesch Y; Walters C; Urist MM; Mann GB; Doherty G; Herrmann VM; Hill AD; Eremin O; El-Sheemy M; Orr RK; Valle AA; Henderson MA; Dewitty RL; Sugg SL; Frykberg E; Yeh K; Bell RM; Metcalf JS; Elliott BM; Brothers T; Robison J; Mitas M; Cole DJ
Ann Surg; 2004 Jun; 239(6):828-37; discussion 837-40. PubMed ID: 15166962
[TBL] [Abstract][Full Text] [Related]
9. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.
Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1996 Sep; 78(6):1235-40. PubMed ID: 8826945
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study for detecting micrometastases of lymph nodes in patients with lung cancer].
Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Tong XY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):19-21. PubMed ID: 18346373
[TBL] [Abstract][Full Text] [Related]
11. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
[TBL] [Abstract][Full Text] [Related]
12. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
[TBL] [Abstract][Full Text] [Related]
13. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
Nissan A; Jager D; Roystacher M; Prus D; Peretz T; Eisenberg I; Freund HR; Scanlan M; Ritter G; Old LJ; Mitrani-Rosenbaum S
Br J Cancer; 2006 Mar; 94(5):681-5. PubMed ID: 16495929
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of axillary lymph node micrometastases in breast cancer.
Sakorafas GH; Geraghty J; Pavlakis G
Eur J Surg Oncol; 2004 Oct; 30(8):807-16. PubMed ID: 15336724
[TBL] [Abstract][Full Text] [Related]
15. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
[TBL] [Abstract][Full Text] [Related]
16. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.
D'Cunha J; Corfits AL; Herndon JE; Kern JA; Kohman LJ; Patterson GA; Kratzke RA; Maddaus MA
J Thorac Cardiovasc Surg; 2002 Mar; 123(3):484-91; discussion 491. PubMed ID: 11882819
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of metastases in axillary lymph nodes of breast cancer.
Inokuchi M; Ninomiya I; Tsugawa K; Terada I; Miwa K
Br J Cancer; 2003 Nov; 89(9):1750-6. PubMed ID: 14583780
[TBL] [Abstract][Full Text] [Related]
18. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.
Bernini A; Spencer M; Frizelle S; Madoff RD; Willmott LD; McCormick SR; Niehans GA; Ho SB; Kratzke RA
Cancer Detect Prev; 2000; 24(1):72-9. PubMed ID: 10757125
[TBL] [Abstract][Full Text] [Related]
19. Detection of hepatocyte growth factor/scatter factor receptor (c-Met) in axillary drainage after operations for breast cancer using reverse transcriptase-polymerase chain reaction.
Greenberg R; Schwartz I; Skornick Y; Kaplan O
Breast Cancer Res; 2003; 5(3):R71-6. PubMed ID: 12793903
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
